Key Takeaways Strong demand for green products and high-value specialties is expected to boost sales and margins, driving revenue growth for Borregaard. Operational improvements and currency hedging could stabilize revenue and enhance financial resilience despite trade and currency challenges.
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construction, as well as to flavour and fragrance companies, and food and beverage industry. It also develops, produces, and sells speciality cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. In addition, the company provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
